The collagen receptor glycoprotein VI promotes platelet-mediated aggregation of {beta}-amyloid
Cerebral amyloid angiopathy (CAA) and β-amyloid (Aβ) deposition in the brain parenchyma are hallmarks of Alzheimer’s disease (AD). We previously reported that platelets contribute to Aβ aggregation in cerebral vessels by secreting the factor clusterin upon binding of Aβ40 to the fibrinogen receptor integrin αIIbβ3. Here, we investigated the contribution of the collagen receptor GPVI (glycoprotein VI) in platelet-induced amyloid aggregation. Using platelets isolated from GPVI–wild type and GPVI-deficient human donors and mice, we found that Aβ40 bound to GPVI, which induced th...
Source: Signal Transduction Knowledge Environment - August 4, 2020 Category: Science Authors: Donner, L., Toska, L. M., Krüger, I., Gröniger, S., Barroso, R., Burleigh, A., Mezzano, D., Pfeiler, S., Kelm, M., Gerdes, N., Watson, S. P., Sun, Y., Elvers, M. Tags: STKE Research Articles Source Type: news

FDA Slams Torrent Over Losartan Manufacturing Lapses FDA Slams Torrent Over Losartan Manufacturing Lapses
The company was cited for quality-control violations and other issues regarding its manufacture of losartan potassium tablets at one of its facilities in India.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 16, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Torrent Pharma recalls 74k bottles of hypertension drug from US
As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from the same markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2019 Category: Pharmaceuticals Source Type: news

Medical News Today: More batches of common hypertension drug taken off the market
Torrent Pharmaceuticals Ltd. is withdrawing more batches of Losartan potassium tablets, USP and Losartan potassium/hydrochlorothiazide tablets, USP. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 27, 2019 Category: Consumer Health News Tags: Hypertension Source Type: news

More Blood Pressure Drugs Recalled
TUESDAY, Sept. 24, 2019 -- The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots. The drug, made by Torrent Pharmaceuticals, has been recalled because some lots are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 24, 2019 Category: Pharmaceuticals Source Type: news

FDA Expands Recall Of Blood Pressure Drugs Again
(CNN) — Torrent Pharmaceuticals Ltd. has expanded its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing. The recall affects Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets. Tests of some of those medications revealed amounts of N-methylnitrosobutyric acid (NMBA) that were above the US Food and Drug Administration’s daily acceptable levels. This recall is related to the valsartan recall that has been expanded multiple times since July, when separate lots of blood pressure medications from dif...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Recall Valsartan Source Type: news

Torrent Recalls More Tainted Losartan Torrent Recalls More Tainted Losartan
It's the fifth recall by Torrent of losartan-containing medicines due to detection of unacceptable levels of a potential carcinogen.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 23, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ghana: Time of Administration Ofanti-Hypertensives - Effect of Chronotherapy
[Ghanaian Times] What is the best time to take my B.P. medications (antihypertensives)? It depends on the medication, and the number of medications. If is a water pill (diuretic such as Bendrofluazide) it is better to take it in the morning because you will be passing a lot of urine. There are some that can make you a bit dizzy, especially for first-timers (e.g. Doxazocin, Lisinopril, Losartan) and are therefore better taken at night. There is another aspect, which needs to be considered. It is referred to as Chronotherapy (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 28, 2019 Category: African Health Source Type: news

Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Torrent Pharmaceuticals Limited is expanding its voluntary recall from 2 lots of Losartan potassium tablets USP to a total of 10 lots, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 30, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)
Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Met (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply
Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)
Earth City, MO, Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. This recall was prompted due to Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, and 100mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)
Recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. This recall was prompted due to Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Legacy Pharmaceutical Packaging, LLC Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)
Legacy Pharmaceutical Packaging, LLC is expanding its consumer-level recall of 3 repackaged lots Losartan Tablets USP 50mg to include one additional lot. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Two MORE blood pressure drugs recalled over carcinogens
Macleods Pharmaceuticals voluntarily recalled 32 lots of two types of its losartan blood pressure medication that contain unsafe levels of the carcinogen NMBA, the US FDA announced on Wednesday (Source: the Mail online | Health)
Source: the Mail online | Health - June 28, 2019 Category: Consumer Health News Source Type: news

ARB Concerns Continue as Macleods Pulls Contaminated Losartan ARB Concerns Continue as Macleods Pulls Contaminated Losartan
The recall comes amid renewed concerns after a recent expanded recall and the discovery of a fourth potential carcinogen in another commonly used hypertension and heart failure medication.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 28, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consumer Level Recall of Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg due to detection of NMBA (N-Nitroso-N ­ Methyl-4-aminobutyric acid) Impurity.
Macleods Pharmaceuticals Limited has initiated a voluntary recall in the United States, to the patient level, of 32 lots of Losartan Potassium USP Tablets (2 lots of 50mg strength) and Losartan Potassium/Hydrochlorothiazide combination Tablets (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Pharmacy Tests Turn Up Another Cancer-Causing Compound In Heart Drugs
(CNN) — Tests by an online pharmacy turned up another cancer-causing compound in heart medications, and these drugs haven’t been recalled. Drugs containing valsaratan, losartan and irbesartan made by a variety of companies in a variety of countries have been taken off pharmacy shelves since July, when tests turned up chemicals in them that are considered carcinogens. The recalls of these angiotensin II receptor blockers or ARBs continue to expand. The US Food and Drug Administration keeps a regularly updated list of the drugs that have been recalled. In this case, it’s not a recall. Instead, Valisure, an ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 19, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Valsartan Source Type: news

Teva Pharmaceuticals Expands Losartan Recall
Teva Pharmaceuticals Expands Patient-Level Losartan Recall (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 13, 2019 Category: General Medicine Source Type: news

Teva Pharmaceuticals Expands Patient-Level Losartan Recall Teva Pharmaceuticals Expands Patient-Level Losartan Recall
The new recall of six lots brings the total to 41 lots of bulk losartan potassium sold to Golden State Medical Supply of California.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 13, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.
This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Novel Neoadjuvant Approach May Boost Surgical Success in Pancreatic Cancer Novel Neoadjuvant Approach May Boost Surgical Success in Pancreatic Cancer
In the majority of studied patients with locally advanced pancreatic cancer, total neoadjuvant treatment with fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFIRINOX) along with losartan and chemoradiation allowed complete tumor removal, according to a single-arm phase 2 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 10, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity
Vivimed Life Sciences Pvt Ltd (Vivimed) is recalling 19 lots of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. Due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 4, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Trial: Gains Seen on Inoperable Pancreatic Cancer
In the clinical trial, 49 patients with locally advanced pancreatic cancer received intensive chemotherapy and radiation therapy, as well as the blood pressure drug losartan. (Source: WebMD Health)
Source: WebMD Health - May 31, 2019 Category: Consumer Health News Source Type: news

Novel protocol significantly improves outcomes in locally advanced pancreatic cancer
(Massachusetts General Hospital) A Massachusetts General Hospital Cancer Center clinical trial of a protocol combining intensive chemotherapy and radiation therapy with the blood pressure drug losartan has produced unprecedented results in patients with locally advanced pancreatic cancer, allowing complete removal of the tumor in 61% of participants and significantly improving survival rates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 30, 2019 Category: Cancer & Oncology Source Type: news

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in th (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 22, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Macleods Pharmaceuticals Limited Issues Voluntary Nationwide Consumer Level Recall of One Lot (BLM 715A) of Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg Due to detection of NDEA (N-Nitrosodiethylamine) Impurity
Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical in (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How Some Generic Drugs Could Do More Harm Than Good
For the 16 years that Dr. Brian Westerberg, a Canadian surgeon, worked volunteer missions at the Mulago National Referral Hospital in Kampala, Uganda, scarcity was the norm. The patients usually exceeded the 1,500 allotted beds. Running water was once cut off when the debt-ridden hospital was unable to pay its bills. On some of his early trips, Westerberg even brought over drugs from Canada in order to treat patients. But as low-cost generics made in India and China became widely available through Uganda’s government and international aid agencies in the early 2000s, it seemed at first like the supply issue had been ...
Source: TIME: Health - May 17, 2019 Category: Consumer Health News Authors: Katherine Eban Tags: Uncategorized generic drugs medication medicine Source Type: news

Metoprolol vs. losartan
Title: Metoprolol vs. losartanCategory: MedicationsCreated: 5/14/2019 12:00:00 AMLast Editorial Review: 5/14/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 14, 2019 Category: Drugs & Pharmacology Source Type: news

More Losartan Joins Recall List, Heritage Pharma Distributors More Losartan Joins Recall List, Heritage Pharma Distributors
Manufacturer Vivimed has recalled 19 lots of its losartan potassium found with the same potential carcinogen that has led to recalls of both losartan and valsartan from various companies.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 6, 2019 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

More Tainted Losartan With Ties to Hetero Labs Recalled More Tainted Losartan With Ties to Hetero Labs Recalled
Teva Pharmaceuticals is just the latest company this month to recall losartan products after detecting nitrosamines in the active pharmaceutical ingredient made by Hetero.News Alerts (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 30, 2019 Category: Neurology Tags: Cardiology News Alert Source Type: news

Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan
Find out which specific blood pressure medications are affected by the recall (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More Questions and Answers: Impurities Found in Certain Angiotensin II Receptor Blocker (ARB) products
Answers to questions about nitrosamine impurities found in valsartan, losartan, and irbesartan and FDA's actions to address the issue (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)
Get updates on the recalls (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Recalls of Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan
Get current information about recalls of blood pressure medications: valsartan, losartan, and irbesartan (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
FDA provides update on ongoing investigation into ARB drugs; new losartan recall announced (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 27, 2019 Category: American Health Authors: FDA Source Type: news

Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply
Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 27, 2019 Category: Food Science Source Type: news

Legacy Pharmaceutical Expands Losartan Recall Legacy Pharmaceutical Expands Losartan Recall
The repackaged lot was distributed nationwide and tied to a larger recall of losartan announced just days ago.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 25, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Legacy Pharmaceutical Packaging, LLC Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)
Legacy Pharmaceutical Packaging, LLC is expanding its consumer-level recall of 3 repackaged lots Losartan Tablets USP 50mg to include one additional lot. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 25, 2019 Category: Food Science Source Type: news

Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from US
The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2019 Category: Pharmaceuticals Source Type: news

Recall of blood pressure drug losartan expanded
If you take blood pressure medicine, you'll want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. (Source: CNN.com - Health)
Source: CNN.com - Health - April 20, 2019 Category: Consumer Health News Source Type: news

Recall Of Blood Pressure Drug Losartan Expanded
(CNN) — If you take blood pressure medicine, you’ll want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs. The company is recalling 36 additional lots, it said Thursday. A full list of recalled drugs is available on the US Food and Drug Administration website. Some of the recalled blood pressure medication (Image credit: FDA) The company hasn’t had any reports of users getting ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 19, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News losartan Source Type: news

Torrent Recalls 104 More Lots of Tainted Losartan Tablets Torrent Recalls 104 More Lots of Tainted Losartan Tablets
The blood pressure tablets contain unacceptable levels of a potential carcinogen nitrosamine impurity that has prompted recalls by the company and other globally.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 19, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The Recall is expanded to include an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 18, 2019 Category: Food Science Source Type: news

Defibrillator Hacking; Losartan Stay of Sentence; Guideline Evidence
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 25, 2019 Category: Urology & Nephrology Source Type: news

Class 2 Medicines recall: Accord Healthcare Limited — Losartan potassium 50mg and 100mg film-coated tablets
Accord Healthcare Limited is recalling some batches of losartan potassium 50mg and 100mg film-coated tablets. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 22, 2019 Category: Drugs & Pharmacology Source Type: news